Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 1, 2007, Pages 307-316

  Ramya, T N C ^a   Mishra, Satyendra ^a   Karmodiya, Krishanpal ^b   Surolia, Namita ^b   Surolia, Avadhesha ^a,c  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^c NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACIFLUORFEN; ANTIBIOTIC AGENT; CERULETIDE; CHLORAMPHENICOL; CHLOROQUINE; CLINDAMYCIN; CYCLOHEXIMIDE; FLUAZIFOP; HALOXYFOP; HEME; PROTEIN SYNTHESIS INHIBITOR; QUIZALOFOP; RIFAMPICIN; SUCCINYLACETONE; TETRACYCLINE; TRICLOSAN; UNCLASSIFIED DRUG;

APICOMPLEXA; APICOPLAST; ARTICLE; CONTROLLED STUDY; GENOME; MICROBIAL METABOLISM; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; SURVIVAL; TOXOPLASMA GONDII;

ACETONE; ANIMALS; ANTIMALARIALS; AZITHROMYCIN; CERULENIN; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROCYTES; FATTY ACIDS; GENE DOSAGE; HUMANS; ORGANELLES; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TETRACYCLINE; THIOCTIC ACID; TRICLOSAN;

EID: 33846026771     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00808-06     Document Type: Article

References (36)

1. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
2. Fichera, M. E., and D. S. Roos. 1997. A plastid organelle as a drug target in apicomplexan parasites. Nature 390:407-409.
3. Geary, T. G., and J. B. Jensen. 1982. Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture. Am. J. Trop. Med. Hyg. 32:221-225.
4. Gilliland, G., S. Perrin, K. Blanchard, and H. F. Bunn. 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:2725-2729.
5. Gleeson, M. T. 2000. The plastid in Apicomplexa: what use is it? Int. J. Parasitol. 30:1053-1070.
6. He, C. Y., M. K. Shaw, C. H. Pletcher, B. Striepen, L. G. Tilney, and D. S. Roos. 2001. A plastid segregation defect in the protozoan parasite Toxoplasma gondii. EMBO J. 20:330-339.
7. Heath, R. J., Y. T. Yu, M. A. Shapiro, E. Olson, and C. O. Rock. 1998. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J. Biol. Chem. 273:30316-30320.
8. Jelenska, J., M. J. Crawford, O. S. Harb, E. Zuther, R. Haselkorn, D. S. Roos, and P. Gornicki. 2001. Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 98:2723-2728.
9. Jomaa, H. J. Wiesner, S. Sanderbrand, B. Altincicek, C. Weidemeyer, M. Hintz, I. Turbachova, M. Eberl, J. Zeidler, H. K. Lichtenthaler, D. Soldati, and E. Beck. 1999. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285:1573-1576.
10. Kapoor, M., M. J. Dar, A. Surolia, and N. Surolia. 2001. Kinetic determinants of the interactions of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. Biochem. Biophys. Res. Commun. 289:832-837.
11. Ki, S. W., K. Ishigami, T. Kitahara, K. Kasahara, M. Yoshida, and S. Horinouchi. 2000. Radicicol binds and inhibits mammalian ATP citrate lyase. J. Biol. Chem. 275:39231-39236.
12. Kohler, S., C. F. Delwiche, P. W. Denny, L. G. Tilney, P. Webster, R. J. Wilson, J. D. Palmer, and D. S. Roos. 1997. A plastid of probable green algal origin in apicomplexan parasites. Science 275:1485-1489.
13. Lambros, C., and J. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
14. Lell, B., R. Ruangweerayut, J. Wiesner, M. A. Missinou, A. Schindler, T. Baranek, M. Hintz, D. Hutchinson, H. Jomaa, and P. G. Kremsner. 2003. Fosmidomycin, a novel chemotherapeutic agent for malaria. Antimicrob. Agents Chemother. 47:735-738.
15. Lindblad, B., S. Lindstedt, and G. Steen. 1977. On the enzymic defects in hereditary tyrosinemia. Proc. Natl. Acad. Sci. USA 74:4641-4645.
16. Matringe, M., J. M. Camadro, P. Labbe, and R. Scalla. 1989. Protoporphyrinogen oxidase as a molecular target for diphenyl ether herbicides. Biochem. J. 260:231-235.
17. McFadden, G. I., and D. S. Roos. 1999. Apicomplexan plastids as drug targets. Trends Microbiol. 7:328-331.
18. McMurray, L. M., M. Oethinger, and S. B. Levy. 1998. Triclosan targets lipid synthesis. Nature 394:531-532.
19. Muller, S. 2004. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol. Microbiol. 53:1293-1305.
20. Parker, W. B., L. C. Marshall, J. D. Burton, D. A. Somers, D. L. Wyse, J. W. Gronwald, and B. G. Gengenbach. 1990. Dominant mutations causing alterations in acetyl-coenzyme A carboxylase confer tolerance to cyclohexanedione and aryloxyphenoxypropionate herbicides in maize. Proc. Natl. Acad. Sci. USA 87:7175-7179.
21. Ralph, S. A., M. C. D'Ombrain, and G. I. McFadden. 2001. The apicoplast as an antimalarial drug target. Drug Resist. Updates 4:145-151.
22. Ralph, S. A., G. G. van Dooren, R. F. Waller, M. J. Crawford, M. J. Fraunholz, B. J. Foth, C. J. Tonkin, D. S. Roos, and G. I. McFadden. 2004. Metabolic functions and maps of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol. 2:203-216.
23. Roos, D. S., M. J. Crawford, R. G. Donald, J. C. Kissinger, L. J. Klimczak, and B. Striepen. 1999. Origins, targeting, and function of the apicomplexan plastid. Curr. Opin. Microbiol. 2:426-432.
24. Rosenthal, P. J. 2001. Antimalarial chemotherapy: mechanism of action, modes of resistance and new directions in drug discovery. Humana Press, Totowa, NJ.
25. Sharma, S. K., M. Kapoor, T. N. C. Ramya, S. Kumar, G. Kumar, R. Modak, S. Sharma, N. Surolia, and A. Surolia. 2003. Identification, characterization and inhibition of Plasmodium falciparum β- hydroxyacyl-acyl carrier protein dehydratase (FabZ). J. Biol. Chem. 278:45661-45671.
26. Sharma, S. V., T. Agatsuma, and H. Nakano. 1998. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol. Oncogene 16:2639-2645.
27. Surolia, A., T. N. C. Ramya, V. Ramya, and N. Surolia. 2004. 'FAS't inhibition of malaria. Biochem. J. 383:1-12.
28. Surolia, N., and G. Padmanaban. 1992. De novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite. Biochem. Biophys. Res. Commun. 187:744-750.
29. Surolia, N., and A. Surolia. 2001. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat. Med. 7:167-173.
30. Toler, S. 2005. The plasmodial apicoplast was retained under evolutionary selective pressure to assuage blood stage oxidative stress. Med. Hypotheses 65:683-690.
31. Trager, W., and J. B. Jenson. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
32. Vance, D., I. Goldberg, O. Mitsuhashi, and K. Bloch. 1972. Inhibition of fatty acid synthetases by the antibiotic cerulenin. Biochem. Biophys. Res. Commun. 48:649-656.
33. Waller, R. F., S. A. Ralph, M. B. Reed, V. Su, J. D. Douglas, D. E. Minnikin. A. F. Cowman, G. S. Besra, and G. I. McFadden. 2003. A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum. Antimicrob. Agents Chemother. 47:297-301.
34. WHO. 2002. Communicable diseases report-roll back malaria (cited 9 January 2004). http://www.who.int/infectious-disease-news/cds2002/chapter7 .pdf.
35. Wilson, R. J., D. H. Williamson, and P. Preiser. 1994. Malaria and other Apicomplexans: the plant connection. Infect. Agents Dis. 3:29-37.
36. Wrenger, C., and S. Muller. 2004. The human malaria parasite Plasmodium falciparum has distinct organelle-specific lipoylation pathways. Mol. Microbiol. 53:103-113.